Type 2 diabetes in pregnancy: A wolf in sheep's clothing

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 45, Issue 6, 2005, Pages 479-483

  Cheung, N Wah ^a   McElduff, Aidan ^a   Ross, Glynis P ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Diabetes mellitus; Pregnancy in diabetics; Pregnancy outcome; Review literature; Type 2 diabetes

Indexed keywords

ACARBOSE; ANTIHYPERTENSIVE AGENT; FOLIC ACID; GLIBENCLAMIDE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

AUSTRALIA; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG TISSUE LEVEL; ETHNOLOGY; FAMILY PLANNING; FETUS MORTALITY; FETUS WASTAGE; GLYCEMIC CONTROL; HEART INFARCTION; HIGH RISK PREGNANCY; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; MATERNAL CARE; MUSCULOSKELETAL SYSTEM MALFORMATION; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COUNSELING; PERINATAL MORBIDITY; PLACENTAL TRANSFER; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIOECONOMICS; UROGENITAL TRACT MALFORMATION; ADULT; COUNSELING; FEMALE; FOLLOW UP; GESTATIONAL AGE; MATERNAL AGE; PATIENT EDUCATION; PREGNANCY; RISK ASSESSMENT; SURVIVAL RATE;

ADULT; AUSTRALIA; COUNSELING; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MATERNAL AGE; PATIENT EDUCATION; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PRENATAL CARE; RISK ASSESSMENT; SURVIVAL RATE;

EID: 33744996952     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2005.00480.x     Document Type: Review

References (36)

1. Dunstan D, Zimmet P, Welborn T et al. The rising prevalence of diabetes and impaired glucose tolerance: The Australian diabetes, obesity and lifestyle study. Diabetes Care 2002; 25: 829-834.
2. McElduff A, Ross GP, Lagström JA et al. Pregestational diabetes and pregnancy: An Australian experience. Diabetes Care 2005; 28: 1260-1261.
3. McElduff A, Cheung NW, McIntyre et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the managemnet of type 1 and type 2 diabetes in relation to pregnancy. Med J Aust 2005; 183: 373-377.
4. Lau SM, Prout R, Cheung NW. Temporal trends in type 2 diabetes in pregnancy. Abstract, Australasian Diabetes in Pregnancy Society Annual Scientific Meeting, 2004.
5. Gunton JE, McElduff A, Sulway M, Stiel J, Kelso I, Boyce S et al. Outcome of pregnancies complicated by pre-gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 2000; 40: 38-43.
6. Gunton JE, Morris J, Boyce S, Kelso I, McElduff A. Outcome of pregnancy complicated by pre-gestational diabetes - improvement in outcomes. Aust NZ J Obstet Gynaecol 2002; 42: 478-481.
7. Coetzee EJ, Jackson WPU. The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Prac 1986; 1: 281-287.
8. Con treras-Soto J, Forsbach G, Vazquez-Rosales J, Alvarez-Garcia C, Garcia G. Noninsulin dependent diabetes mellitus and pregnancy in Mexico. Int J Gynecol Obstet 1991; 34: 205-210.
9. Omori Y, Minei S, Testuo T, Nemoto K, Shimizu M, Sanaka M. Current status of pregnancy in diabetic women. A comparison of pregnancy in IDDM and NIDDM mothers. Diabetes Res Clin Pract 1994; 24: S273-S278.
10. Sacks DA, Chen W, Greenspoon JS, Wolde-Tsadik G. Should the same glucose values be targeted for type 1 as for type 2 diabetics in pregnancy? Am J Obstet Gynecol 1997; 177: 1113-1119.
11. Zhu L, Nakabayashi M, Takeda Y. Statistical analysis of perinatal outcomes in pregnancy complicated with diabetes mellitus. J Obstet Gynecol 1997; 23: 555-563.
12. Brydon P, Smith T, Proffitt M, Gee H, Holder R, Dunne F. Pregnancy outcome in women with type 2 diabetes mellitus needs to be addressed. Int J Clin Pract 2000; 54: 418-419.
13. Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med 2002; 19: 322-326.
14. Diabetes and Pregnancy Group, France. French multicentric survey of oucome of pregnancy in women with pregestational diabetes. Diabetes Care 2003; 26: 2990-3010.
15. Clausen TD, Hellmuth E, Mathiesen E, Mandrupp-Poulsen T, Ekbom P, Damm P. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 2005; 28: 323-328.
16. Daniel M, Rowley KG, McDermott R., Mylvaganam A, Odea K. Diabetes incidence in an Australian Aboriginal population. Diabetes Care 1999; 22: 1993-1998.
17. Cundy T, Gamble G, Townend K, Henley PG, MacPherson P, Roberts AB. Perinatal mortality in type 2 diabetes mellitus. Diabetic Med 2000; 17: 33-39.
18. Dunne F, Brydon P, Smith K, Gee H. Pregnancy in women with type 2 diabetes: 12 years outcome data 1990-2002. Diabet Med 2003; 20: 734-738.
19. Hadden DR, Cull CA, Croft DJ, Holman RR. Poor pregnancy outcome for women with type 2 diabetes. Diabet Med 2003; 20: 506-507.
20. Kristensen J, Vestergard M, Wisborg K, Kesmodel U, Secher NJ. Pre-pregnancy weight and the risk of stillbirth and neonatal death. Br J Obstet Gynaecol 2005; 112: 403-408.
21. Towner D, Kjos SL, Leung B, Montoro MM, Xiang A, Mestman JH, Buchanan TA. Congenital malformations in pregnancies complicated by NIDDM. Increased risk from poor metabolic control but not from exposure to sulfonylurea drugs. Diabetes Care 1995; 18: 1446-1451.
22. Schaefer-Graf UM, Buchanan TA, Xiang A, Songster G, Montoro M, Kjos SL. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 2000; 182: 313-320.
23. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: A meta-analysis. QJM 2001; 94: 435-444.
24. McIntyre HD, Flack JR. Consensus statement on diabetes control in press for pregnancy. Med J Aust 2004; 181: 326.
25. Bagg W, Henley PG, Macpherson P, Cundy TF. Pregnancy in women with diabetes and ischaemic heart disease. Aust N Z J Obstet Gynaecol 1999; 39: 99-102.
26. ACOG Practic Bulletin 60. Pregestational diabetes. Obstet Gynecol 2005; 105: 675-682.
27. Gutzin SJ, Kozer E, Magee LA, Feig DS, Koren G. The safety of oral hypoglycaemic agents in the first trimester of pregnancy: A meta-analysis. Can J. Clin. Pharmacol. 2003; 10: 179-183.
28. Vanky E, Zahlsen K, Spigset O, Carlsen S. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 2005; 83: 1575-1578.
29. Langer O, Con way DL, Berkus MD, Xenakis EM-J, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000; 343: 1134-1138.
30. Homko CJ, Sivian E, Reece AE. Is there a role for oral antihyperglycemics in gestational diabetes and type 2 diabetes in pregnancy? Treat Endocrinol 2004; 3: 133-139.
31. Merlob P, Levitt O, Stahl B. Oral antihyperglycemic agents during pregnancy and lactation. Pediatr Drugs 2002; 4: 755-760.
32. Preece R, Jovanovic L. New and future diabetes therapies: Are they safe during pregnancy? J Matern Fetal Neonatal Med 2002; 12: 365-375.
33. Tran ND, Hunter SK, Yankowitz J. Oral hypoglycemic agents in pregnancy. Obstet Gynecol Survey 2004; 59: 456-463.
34. Saade G. Gestational diabetes mellitus: A pill or a shot. Obstet Gynecol 2005; 105: 456-457.
35. ADA. Position statement. Diabetes Care 2004; 27: 226-229.
36. Edison RJ, Muenke M. Central nervous system and limb anomalies in case reports of first trimester statin exposure. N Eng J Med 2004; 350: 1579-1582.